CVS Health Corp (CVS · NYSE)

CVS · MARKET VIEW

Market view · as of Sep 7, 2026

Revenue (TTM)
$412.64B
+7.1% YoY
Gross margin
13.6%
EPS (latest q)
$2.58
vs $1.87 est · beat
52-wk position
68.5%
-12.0% vs 52w high · +1.1% 1mo

Price (last ~year)

CVS Health Corp reported Q2 2026 revenue of $106.10 billion, a 7.1% year-over-year increase, while earnings grew 188.8% over the same period. The company has surpassed earnings estimates in each of the last four quarters, most recently posting $2.58 per share against an expected $1.87. CVS maintains a market capitalization of $123.73 billion, with $76.31 billion in total debt and a debt-to-EBITDA ratio of 4.6x. Institutional activity in the second quarter included multiple firms increasing their holdings in the company.

Valuation

Market cap
$123.73B
P/E
25.53
PEG
0.228
P/B
1.56
P/S
0.3
EV/EBITDA
13.92
Beta
0.58
Analyst target
$116.04

Quality & returns

Gross margin
13.6%
Operating margin
3.9%
Profit margin
1.2%
ROE
6.2%
ROA
3.0%

Price movement

Last
$96.74
1-month
+1.1%
3-month
-0.7%
RSI (14)
60
vs SMA200
+13.0%
52-wk position
68.5% -12.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$106.10B$4.70B$3.00B$5.86B
2026-03-31$100.43B$4.68B$2.94B$5.83B
2025-12-31$105.69B$2.11B$2.94B$3.29B
2025-09-30$102.87B$-3.21B$-3.98B$-1.56B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots